Aldosterone, Mineralocorticoid Receptor and the Metabolic Syndrome:Role of the Mineralocorticoid Receptor Antagonists

By  

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 238-246

Bentham Science Publishers

Access to resources Recommend Favorite

Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed‐Methods Study

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 3, 2016-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiogenesis antagonists: current clinical trials

By Brem S.  

Angiogenesis, Vol. 2, Iss. 1, 1998-01 ,pp. : 9-20

Springer Publishing Company

Access to resources Recommend Favorite

Proarrhythmic Effects of Post-Operative Pacing Intended to Prevent Atrial Fibrillation: Evidence from a Clinical Trial

By Chung M.K.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 2, 2003-01 ,pp. : 143-146

Springer Publishing Company

Access to resources Recommend Favorite

Examining the appropriateness of radial or femoral access: evidence from the RIVAL trial and clinical practice

By Hale Sarah   Mann Tift  

Interventional Cardiology, Vol. 4, Iss. 6, 2012-12 ,pp. : 675-687

Future Medicine

Access to resources Recommend Favorite